2024-11-25 2025-11-30 false No description of principal activity Capium Accounts Production 1.1 16100911 2024-11-25 2025-11-30 16100911 bus:FullAccounts 2024-11-25 2025-11-30 16100911 bus:Micro-entities 2024-11-25 2025-11-30 16100911 bus:AuditExempt-NoAccountantsReport 2024-11-25 2025-11-30 16100911 bus:SmallCompaniesRegimeForAccounts 2024-11-25 2025-11-30 16100911 bus:PrivateLimitedCompanyLtd 2024-11-25 2025-11-30 16100911 2024-11-25 2025-11-30 16100911 2025-11-30 16100911 bus:RegisteredOffice 2024-11-25 2025-11-30 16100911 core:WithinOneYear 2025-11-30 16100911 core:AfterOneYear 2025-11-30 16100911 1 2024-11-25 2025-11-30 16100911 bus:Director1 2024-11-25 2025-11-30 16100911 bus:Director1 2025-11-30 16100911 bus:Director2 2024-11-25 2025-11-30 16100911 bus:Director2 2025-11-30 16100911 bus:Director3 2024-11-25 2025-11-30 16100911 bus:Director3 2025-11-30 16100911 2023-11-25 16100911 bus:LeadAgentIfApplicable 2024-11-25 2025-11-30 16100911 2024-11-24 16100911 core:FurnitureFittings 2024-11-25 2025-11-30 16100911 core:FurnitureFittings 2025-11-30 16100911 core:FurnitureFittings 2024-11-24 16100911 core:ComputerEquipment 2024-11-25 2025-11-30 16100911 core:ComputerEquipment 2025-11-30 16100911 core:ComputerEquipment 2024-11-24 16100911 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 16100911 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-11-24 16100911 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 16100911 core:CostValuation core:Non-currentFinancialInstruments 2024-11-24 16100911 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 16100911 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16100911 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16100911 core:Non-currentFinancialInstruments 2025-11-30 16100911 core:Non-currentFinancialInstruments 2024-11-24 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16100911
England and Wales

 

 

 

HASSEAN HEALTH LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 25 November 2024

End date: 30 November 2025
Directors Michael Lewis STEIN
Jussi Pekka WESTERGREN
Maxwell Keith CHAPMAN
Registered Number 16100911
Registered Office 9th Floor
107 Cheapside
London
EC2V 6DN
Accountants Infina Financial Limited
66 Paul Street
London
EC2A 4NA
1
  2025
    £ £
Fixed assets   4,275 
Current assets 1,620,175   
Creditors: amount falling due within one year (117,948)  
Net current assets   1,502,227 
Total assets less current liabilities   1,506,502 
Net assets   1,506,502 
 

     
Capital and reserves   1,506,502 
 
NOTES TO THE ACCOUNTS

General information
Hassean Health Limited is a private company, limited by shares, registered in England and Wales, registration number 16100911, registration address 9th Floor, 107 Cheapside, London, EC2V 6DN.


These financial statements cover the period from 25 November 2024 (date of incorporation) to 30 November 2025, being the Company's first accounting period. Accordingly, no comparative information is presented. As the period of account exceeds twelve months, the amounts presented in the financial statements may not be entirely comparable with amounts that will be presented in subsequent annual financial statements.
1.

Average number of employees

Including directors and key management personnel.
Average number of employees during the period was 2.


For the period ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 28 July 2026 and were signed on its behalf by:


--------------------------------
Michael Lewis STEIN
Director
2